Initial research on multi‐PIK3CA mutations has predominantly focused on breast cancer; however, the frequency, mutation sites, co‐occurrence with other genomic alterations, and their links to mutational signatures in other cancer types are not well understood. Here, PIK3CA is linked to breast carcinoma.